| | Investigating the effect of pharmaceutical companies' gifts on doctors' prescribing behavior in Jordan | Abrar Ghaith, Hani Aldmour and Ibrahim Alabbadi | European Journal of Social Sciences | 36( 4): pp.528-536 | Taylor & Francis Group | 2013 |
|  | Investigating the factors affecting doctor's prescribing behavior in Jordan: Anti-hypertensive drugs as an example | Eiman Abulhaj, Amjad Abu Elsamen and Ibrahim Alabbadi | European Journal of Social Sciences | 38 (3): pp. 380-391 | Taylor & Francis Group | 2013 |
|  | Investment opportunities in health: Feasibility of building an American private hospital in Jordan | Ibrahim Alabbadi, Azmi Mahafza, Mousa M. Al-Abbadi and Amir Bakir | European Journal of Social Sciences | Vol. 40, No. 2, pages: 312-329 | Taylor & Francis Group | 2013 |
|  | The price of medicines in Jordan: the cost of trade-based intellectual property | Ryan B Abbott, Rania Bader, Lina Bajjali, Taher Abu ElSamen,Thamer Obeidat, Hanan Sboul, Mustafa Shwayat and Ibrahim Alabbadi | Journal of Generic Medicines | 9(2): 75–85 | Sage Publications | 2012 |
|  | A comparison of generic and originator brand drug prices between Jordan and the United Kingdom | Faris El-Dahiyat, Reem Kayyali and Ibrahim Alabbadi | Accepted for publication in Jordan Journal of Pharmaceutical Sciences | Volume 4, No 1 | The Deanship of Academic Research – University of Jordan | 2011 |
|  | Cost impact of purchasing pharmaceuticals jointly in the public health sector in Jordan. | Ibrahim Alabbadi | Journal of Generic Medicines | Vol. 4, No. 2: 97-104 | The Deanship of Academic Research – University of Jordan | 2011 |
|  | Piloting the development of a cost-effective evidence-informed clinical pathway: managing hypertension in Jordanian primary care | Kalipso Chalkidou, Joanne Lord, Nour A. Obeidat, Ibriham A. Alabbadi, Adrian G. Stanley, Rania Bader, Aiman Momani, Rachel M. O’Mahony, Lara Qatami, Derek Cutler | International Journal for Technology Assessment in Healthcare | 27 (2), 151-158 | Cambridge University | 2011 |
| | Impact of electronic academic staff websites for scientific research documentation on world universities ranking: University of Jordan challenge | Ibrahim Alabbadi, Renad Al-Momani, Hala Khyami-Horani | 11th INTERNATIONAL EDUCATIONAL TECHNOLOGY CONFERENCE, Istanbul University, Istanbul, TURKEY | Proceedings Book, Volume 1: 597-600 | | 2011 |
|  | Statin prescribing in Northern Ireland and England pre and post introduction of the Quality and Outcomes Framework | Ibrahim Alabbadi, Grainne Crealey, Kathryn Turner, Therese Rafferty, Lynn Keenan, Penny Murray and James McElnay | Pharm World & Sci | 32 (1); 43-51 | SpringerLink-Springer Science+Media – United Kingdom | 2010 |
|  | Over-The -Counter Drugs’ Price Deregulation in Jordan: the Case of Paracetamol | Ali Al-Maaieh, Ahmad Oran and Ibrahim Alabbadi | Jordan Medical Journal | 44 (2); 208-215 | The Deanship of Academic Research – University of Jordan | 2010 |
|  | One-year Assessment of Joint Procurement of Pharmaceuticals in the Public Health Sector in Jordan | Ibrahim Al-Abbadi, Abdelraouf Qawwas, Mahmoud Jaafreh, Taher Abosamen and Maisa Saket | Clinical Therapeutics | 31(6): 1335-43 | ELSEVIER - Thomson Scientific | 2009 |
|  | Pharmacy Students' Perceptions of the Teaching Evaluation Process in Jordan | Ibrahim Al-Abbadi, Fadi Alkhateeb, Nile Khanfar, Bahaudin Mujtaba and Latif David | Education, Business and Society: Contemporary Middle Eastern Issues | Vol. 2, No. 3, P. 181-190 | Emerald Group Publishing Ltd / United Kingdom | 2009 |
|  | ISPOR International Fellowship Award Report | Ibrahim Al-Abbadi | ISPOR CONNECTIONS-ISPOR CORNER; March/April 2009 issue | page 11 | International Society for PharmacoEconomics and Outcomes Research | 2009 |
|  | Health Care Equity Issues in Middle East | Ibrahim Al-Abbadi | ISPOR CONNECTIONS-POLICY ANALYSIS; July/August 2009 issue | page 8-9 | International Society for PharmacoEconomics and Outcomes Research | 2009 |
|  | Safe Therapeutic Economic Pharmaceutical Selection (STEPS): development, introduction and use in Northern Ireland | Mike Scott, Mark Timony, Jill Mairs, Grainne Crealey, Ibrahim Al Abbadi, Rob Brenninkmeijer, Robert Janknegt and James McElnay | Expert Opin. Pharmacother | 8(Suppl. 1): S57-S63 | Informa Healthcare – United Kingdom | 2007 |
|  | Matrix models and STEPS: concluding remarks | Mike Scott, Mark Timony, Jill Mairs, Grainne Crealey, Ibrahim Al Abbadi, Rob Brenninkmeijer, Robert Janknegt and James McElnay | Expert Opin. Pharmacother | 8(Suppl. 1): S65-S67 | Informa Healthcare – United Kingdom | 2007 |
|  | Impact of modified System of Objectified Judgment Analysis (SOJA) methodology on prescribing costs of ACEIs | Grainne Crealey, Michael Scott, Simon Baird, Tom Trouton, Jill Mairs and James McElnay. | Clinical Drug Investigation | 26 (9): 485-94 | ADIS International Limited - United Kingdom | 2006 |